Evidence Table: Pneumococcal Vaccine for Adults

Annotated Bibliography Instructions:

Please use the following articles for my Evidence Table Assignment. I have also attached one evidence table word document for an example. You should follow the exact same way as an example evidence table. Used 10 articles from the following lists.
This assignment is based on previous order # 00156307 and needs good quality with the same writer.
Articles Lists:
1. Andreoni, M., Sticchi, L., Nozza, S., Sarmati, L., Gori, A., Tavio, M., & Society for Infectious and Tropical Diseases (SIMIT). (2021). Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations. Human Vaccines & Immunotherapeutics, 17(11), 4265-4282.
2. Briggs, L., Fronek, P., Quinn, V., & Wilde, T. (2019). Perceptions of influenza and pneumococcal vaccine uptake by older persons in Australia. Vaccine, 37(32), 4454-4459. https://doi(dot)org/10.1016/j.vaccine.2019.06.079
3. Cafiero-Fonseca, E. T., Stawasz, A., Johnson, S. T., Sato, R., & Bloom, D. E. (2017). The full benefits of adult pneumococcal vaccination: A systematic review. PLoS One, 12(10), e0186903.
4. Center for Disease Control (2022). COPD: National Trends. https://www(dot)cdc(dot)gov/copd/data-and-statistics/national-trends.html.
5. Fathima, M., Bawa, Z., Mitchell, B., Foster, J., Armour, C., & Saini, B. (2021). COPD management in community pharmacy results in improved inhaler use, immunization rate, COPD action plan ownership, COPD knowledge, and reductions in exacerbation rates. International Journal of Chronic Obstructive Pulmonary Disease, 16, 519.
6. Fekete, M., Pako, J., Nemeth, A. N., Tarantini, S., & Varga, J. T. (2020). Prevalence of influenza and pneumococcal vaccination in chronic obstructive pulmonary disease patients in association with the occurrence of acute exacerbations. Journal of Thoracic Disease, 12(8), 4233. 10.21037/jtd-20-814
7. Froes, F., Roche, N., & Blasi, F. (2017). Pneumococcal vaccination and chronic respiratory diseases. International Journal of Chronic Obstructive Pulmonary Disease, 12, 3457.
8. Ho, H. J., Tan, Y.-R., Cook, A. R., Koh, G., Tham, T. Y., Anwar, E., Hui Chiang, G. S., Lwin, M. O., & Chen, M. I. (2019). Increasing Influenza and Pneumococcal Vaccination Uptake in Seniors Using Point-of-Care Informational Interventions in Primary Care in Singapore: A Pragmatic, Cluster-Randomized Crossover Trial. American Journal of Public Health, 109(12), 1776–1783. https://doi(dot)org/10.2105/ajph.2019.305328
9. Hurley, L. P., Beaty, B., Lockhart, S., Gurfinkel, D., Breslin, K., Dickinson, M., ... & Kempe, A. (2018). RCT of centralized vaccine reminder/recall for adults. American Journal of Preventive Medicine, 55(2), 231-239.
10. Jacobson Vann, J. C., Jacobson, R. M., Coyne-Beasley, T., Asafu-Adjei, J. K., & Szilagyi, P. G. (2018). Patient reminder and recall interventions to improve immunization rates. Cochrane Database of Systematic Reviews, 2018(1). https://doi(dot)org/10.1002/14651858.cd003941.pub3
11. Klassing, H. M., Ruisinger, J. F., Prohaska, E. S., & Melton, B. L. (2018). Evaluation of pharmacist-initiated interventions on vaccination rates in patients with asthma or COPD. Journal of Community Health, 43(2), 297-303.
12. Kuehne, F., Sanftenberg, L., Dreischulte, T., & Gensichen, J. (2020). Shared Decision Making Enhances Pneumococcal Vaccination Rates in Adult Patients in Outpatient Care. International Journal of Environmental Research and Public Health, 17(23), 1–15. https://doi(dot)org/10.3390/ijerph17239146
13. Stolpe, S., & Choudhry, N. K. (2019). Effect of automated immunization registry-based telephonic interventions on adult vaccination rates in community pharmacies: a randomized controlled trial. Journal of Managed Care & Specialty Pharmacy, 25(9), 989-994. https://doi(dot)org/10.18553/jmcp.2019.25.9.989
14. Trethewey, S. P., Patel, N., & Turner, A. M. (2019). Interventions to Increase the Rate of Influenza and Pneumococcal Vaccination in Patients with Chronic Obstructive Pulmonary Disease: A Scoping Review. Medicina, 55(6), 277–276. https://doi(dot)org/10.3390/medicina55060277
15. Walters, J. A., Tang, J. N. Q., Poole, P., & Wood‐Baker, R. (2017). Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, (1).
16. Wise, R. A. (2022). The Quality of Care and Economic Burden of COPD in the United States: Considerations for Managing Patients and Improving Outcomes. https://www(dot)ahdbonline(dot)com/issues/2022/june-2022-vol-15-no-2/3223-the-quality-of-care-and-economic-burden-of-copd-in-the-united-states-considerations-for-managing-patients-and-improving-outcomes

Annotated Bibliography Sample Content Preview:

Name
Title
EVIDENCE TABLE
CITATION
Author(s), Date, Title, Journal Information, DOI

Level of Evidence

PURPOSE / BACKGROUND
Purpose & Outcome Measures or Goals (Aims)

PARTICIPANTS / SETTING
Sample & Setting

METHODS / DESIGN
Study Design & Interventions

RESULTS / LIMITATIONS / RECOMMENDATIONS
Results, Strengths/Weaknesses, Limitations, & Recommendations

Cafiero-Fonseca, E. T., Stawasz, A., Johnson, S. T., Sato, R., & Bloom, D. E. (2017). The full benefits of adult pneumococcal vaccination: A systematic review. PLoS One, 12(10), e0186903. https://doi.org/10.1371/journal.pone.0186903.

I

Background
Pneumococcal vaccine for adults can be effectively used to minimize the burdens associated with pneumococcal diseases.
Purpose
The researchers conducted a study to explore the extent to which the existing literature identifies all the benefits of the pneumococcal vaccine. The second objective of the study was to identify the types of benefits recognized in the literature review.
Aims
Specifically, the paper aimed to identify the depth and breadth of the findings showing that adult pneumococcal vaccines are beneficial.

5,857 papers were identified with 150 of them included in the final review

Systematic review: Studies published between January 2010 and 2016 examining the benefits of pneumococcal vaccines were included in the review.

Results
Majority of studies examining the benefits of the pneumococcal vaccine capture the health advantages associated with the pneumococcal vaccine and savings but do not consider other essential benefits such as productivity due to the vaccine's use. The narrow benefits captured in the study were cost savings, with the broad benefits captured in the studies being outcome-related gains in productivity and care-related productivity gains
Strengths
The review explores all the studies published on the benefits of pneumococcal vaccines.
Limitations
First, the study included only English-published studies. Second, the review did not use a standard bias assessment tool for the included studies. Third, the societal perspective as included in the studies was not defined explicitly.
Recommendation
The full benefits of pneumococcal are undervalued.

Fathima, M., Bawa, Z., Mitchell, B., Foster, J., Armour, C., & Saini, B. (2021). COPD management in community pharmacies results in improved inhaler use, immunization rate, COPD action plan ownership, COPD knowledge, and reductions in exacerbation rates. International Journal of Chronic Obstructive Pulmonary Disease, 16, 519. https://doi.org/10.2147/COPD.S288792

IV

Background
COPD negatively affects the quality of a patient’s life but early interventions can reduce the exacerbation of COPD, lead to reduced care costs, and enhance the quality of life.
Purpose
The objective of the current study was to investigate the effectiveness of a pharmacy care model that helped patient improve their adherence to medication, inhaler technique, and uptake of prevention activities.
Outcome Measures
The primary outcome measure was a change in the number of correct inhale...

Updated on January 26, 2024

Get the Whole Paper!

Not exactly what you need?

Do you need a custom essay? Order right now:

Order

Evidence Table: Pneumococcal Vaccine for Adults

You Might Also Like Other Topics Related to vaccination: